Đang chuẩn bị liên kết để tải về tài liệu:
Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: An interim analysis from the observational, prospective ACTION study

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG Tải xuống

The emergence of new therapies for the treatment of rheumatoid arthritis (RA), the paucity of head-to-head studies, and the heterogeneous nature of responses to current biologics highlight the need for the identification of prognostic factors for treatment response and retention in clinical practice. |